Fierce Pharma Biopharma News & Insights
Fierce Pharma delivers breaking news and analysis about drug companies, the FDA and the broader pharma industry, including manufacturing, marketing and finance.
Top 20 pharma companies by 2023 revenue - Fierce Pharma
Top 20 pharma companies by 2023 revenue. Novo Nordisk and Eli Lilly had huge revenue gains in 2023, while sellers of COVID products Pfizer, Moderna and BioNTech saw major sales declines.
The top 20 drugs by worldwide sales in 2023 | Fierce Pharma
2024年5月28日 · It's been several years since COVID-19 vaccines from Pfizer and Moderna jumped to the top of the pharma industry's sales charts, displacing longtime stalwarts with unprecedented sales. But, as ...
The top 10 vaccine companies worldwide - Fierce Pharma
What a difference five years—and a global pandemic—can make in reshaping an industry. When Fierce Pharma last published our rankings of the top vaccine players back in 2017, we highlighted the ...
Big Pharma Companies Ranked by Revenue 2022 - Fierce Pharma
2023年4月18日 · The top 20 pharma companies by 2022 revenue. By Kevin Dunleavy Apr 18, 2023 12:00am. Johnson & Johnson Pfizer revenue growth Roche. For the first time in biopharma history, a company has topped ...
Pharma | Fierce Pharma
2024年10月14日 · Pfizer’s tafamidis needs a minimum 85% discount from its annual list price to meet commonly accepted cost-effectiveness thresholds, ICER says. Angus Liu Oct 21, 2024 2:55pm. Connect.
The top 20 drugs by 2021 sales - Fierce Pharma
Aside from the four COVID products, three other fast risers bolted into the top 20 last year. After a 55% increase in sales from 2020 to 2021, Regeneron and Sanofi’s Dupixent vaulted into the No ...
Top 20 Pharmaceutical Companies by Revenue 2021 | FiercePharma
2021年3月29日 · The pharma industry quickly took center stage when COVID-19 caught the world off guard early last year. As 2020 progressed, drugmakers battled the coronavirus on one hand and on the other ...
Asia - Fierce Pharma
2024年10月11日 · Lilly, Gilead-Yuhan, Leqembi—Fierce Pharma Asia. Lilly is making a series of investments in China. Gilead ended a MASH deal with Yuhan. A study suggests Leqembi's vial design is wasteful. Angus ...
The top 20 pharma companies by 2021 revenue
It was a good year to be a pharmaceutical company, especially one that came up with a product to combat COVID-19. Of the world’s top 20 pharmas ranked by 2021 revenues, 12 had at least 10% ...